|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01200641 |
|
Date of registration:
|
10/09/2010 |
|
Primary sponsor: |
|
|
Public title:
|
Evaluation of Anxiolysis and Pain Associated With Retrobulbar Eye Block for Cataract Surgery : Melatonin Versus Gabapentin
|
|
Scientific title:
|
Evaluation of Anxiolysis and Pain Associated With Retrobulbar Eye Block for Cataract Surgery : Melatonin Versus Gabapentin ( A Randomized, Double-blind, Placebo-controlled Study) |
|
Date of first enrolment:
|
September 2010 |
|
Target sample size:
|
90 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01200641 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
|
|
|
Countries of recruitment
|
|
Iran, Islamic Republic of
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- patients who were aged 25 years or older, American Society of Anesthesiologists (ASA) physical status I-III
Exclusion Criteria:
- Patients with ASA status IV
- history of hepatic or renal disease, confusion, dementia
- communication difficulty resulting from deafness or language barrier
- chronic use of narcotics, barbiturates or psychotropic medications
- history of allergy or contraindications to any of the study drugs
- visual impairment of the non operative eye
- weight < 40 kg or > 100 kg
Age minimum:
35 Years
Age maximum:
85 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Anxiety
|
|
Pain
|
|
Intervention(s)
|
|
Drug: Gabapentin
|
|
Drug: Melatonin
|
|
Drug: placebo
|
|
Primary Outcome(s)
|
|
anxiety will be assessed by verbal anxiety score (VAS) of 10 (0 = completely calm and 10 = the worst possible anxiety)
[Time Frame: At the end of surgery the patients were asked about average level of their pain during the operation period according to the VPS explained to them before premedication)]
|
|
anxiety will be assessed by verbal anxiety score (VAS) of 10 (0 = completely calm and 10 = the worst possible anxiety)
[Time Frame: one minute after retrobulbar block placement]
|
|
anxiety will be assessed by verbal anxiety score (VAS) of 10 (0 = completely calm and 10 = the worst possible anxiety)
[Time Frame: postoperatively before discharging the patient from the recovery room]
|
|
pain will be assessed by verbal pain score (VPS) of 10 (0 = no pain and 10 = worst pain imaginable)
[Time Frame: At the end of surgery the patients were asked about average level of their pain during the operation period according to the VPS explained to them before premedication)]
|
|
pain will be assessed by verbal pain score (VPS) of 10 (0 = no pain and 10 = worst pain imaginable)
[Time Frame: one minute after retrobulbar block placement]
|
|
pain will be assessed by verbal pain score (VPS) of 10 (0 = no pain and 10 = worst pain imaginable)
[Time Frame: postoperatively before discharging the patient from the recovery room]
|
|
Secondary Outcome(s)
|
|
heart rate will be assessed by echocardiogram monitoring
[Time Frame: before premedication]
|
|
heart rate will be assessed by echocardiogram monitoring
[Time Frame: during the operation period(five minutes after beginning of surgery]
|
|
heart rate will be assessed by echocardiogram monitoring
[Time Frame: ninety minutes after premedication, on arrival in the operating room]
|
|
heart rate will be assessed by echocardiogram monitoring
[Time Frame: one minute after retrobulbar block placement]
|
|
heart rate will be assessed by echocardiogram monitoring
[Time Frame: postoperatively before discharge the patient from the recovery room]
|
|
mean arterial blood pressure will be assessed by noninvasive automatic blood pressure measurement
[Time Frame: before premedication]
|
|
mean arterial blood pressure will be assessed by noninvasive automatic blood pressure measurement
[Time Frame: during the operation period(five minutes after beginning of surgery]
|
|
mean arterial blood pressure will be assessed by noninvasive automatic blood pressure measurement
[Time Frame: ninety minutes after premedication, on arrival in the operating room]
|
|
mean arterial blood pressure will be assessed by noninvasive automatic blood pressure measurement
[Time Frame: one minute after retrobulbar block placement]
|
|
mean arterial blood pressure will be assessed by noninvasive automatic blood pressure measurement
[Time Frame: postoperatively before discharge the patient from the recovery room]
|
|
satisfaction of surgeon according to three degree scale as very bad, moderate, good will be assessed
[Time Frame: at the end of surgery]
|
|
satisfaction of surgeon according to three degree scale as very bad, moderate, good will be assessed
[Time Frame: one minute after retrobulbar block placement]
|
|
Secondary ID(s)
|
|
ACTRN12610000727044
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|